Metronom Health
Roy Cosan has a diverse work experience in various leadership positions. From 2013 to present, they have served as the President of Renova Therapeutics. Prior to that, from 2011 to present, they were the CEO of Metronom Health. From 2010 to 2013, they held the CEO position at Prelude Inc. Additionally, from 2010 to 2013, they were the Managing Director at Fjord Ventures.
Roy Cosan attended Western Michigan University - Haworth College of Business. However, no information is available regarding the specific years of their enrollment, the degree they pursued, or their field of study.
This person is not in any teams
Metronom Health
Metronom Health is an early-stage medical device company, focusing on developing an innovative, Opto-enzymatic continuous blood glucose monitoring technology, for people living with diabetes. Its proprietary technology is believed to provide very significant improvements over available Continuous Glucose monitoring technologies, in terms ofaccuracy in the hypo-glycemic range, reliability, user-friendliness, at a price for the user amenable to broader adoption and easier coverage. The company was incorporated in 2009 and is based in Laguna Hills, California.